Insomnia - Global Market Outlook (2017-2023)

Insomnia - Global Market Outlook (2017-2023)

  • Published: October 2017
  • ID: SMRC16786

According to Stratistics MRC, the Global Insomnia market is expected to grow from $XX million in 2016 to reach $XX million by 2023 with a CAGR of XX%. Working in rational shifts & stressful work conditions, recent technological advancements and increasing demand for OTC sleep aids are some of the factors favoring the market growth. In addition, presence of large undiagnosed insomnia population pool and untapped markets in developing economies are the key opportunities for the market growth. On the contrary, side effects of benzodiazepine and non-benzodiazepine drugs, expiration of patients and increase in non pharmacological therapies are hindering the market growth.

Insomnia is a sleep disorder where in the person faces difficultly to sleep or remain asleep. The indications include depression, irritability, low stamina and daytime sleepiness. It is a highly predominant disorder that affects millions of people, globally. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions. Furthermore, usage of drugs, such as alcohol, nicotine and caffeine will lead to insomnia.

In 2016, North America accounted for the highest market share in the insomnia market and is expected to maintain its dominance throughout the forecast period. In the U.S., the OTC treatment market is expected to hold a greater CAGR to address its growth in the insomnia pharmacological treatment. It is predicted to earn backing from the increasing utilization of melatonin valerian and roots, outstanding to their crucial advantages such as reduced stress levels and low side effects. Asia Pacific also appeared as a proper opportunity to capitalize on with the lifting disposable income and upsurge in the occurrence of chronic diseases.

Some of the key players in global insomnia market include Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, Eisai Co., Flynn Pharma, Johnson & Johnson, Meda Consumer Healthcare Inc., Merck & Co. Inc., Neurim, Pernix, Therapeutics, Pfizer Inc, Purdue Pharma L.P., Sanofi Pasteur, SkyePharma and Takeda Pharmaceutical Company.

Therapy Type Covered:
• Pharmacological Therapy
• Non-pharmacological Therapy

Disorder Durations Covered:
• Chronic Insomnia
• Transient Insomnia
• Acute Insomnia

Disorder Conditions Covered:
• Sleep onset and/or Maintenance
• Poor Quality of Sleep
• Other Disorder Condition

Formulation Types Covered:
• Capsules
• Tablets
• Oral mists

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary   
     
2 Preface   
 
 2.1 Abstract   
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology 
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions 
     
3 Market Trend Analysis  
 3.1 Introduction  
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities  
 3.5 Threats   
 3.6 Emerging Markets  
 3.7 Futuristic Market Scenario 
     
4 Porters Five Force Analysis  
 4.1 Bargaining power of suppliers 
 4.2 Bargaining power of buyers 
 4.3 Threat of substitutes  
 4.4 Threat of new entrants 
 4.5 Competitive rivalry  
     
5 Global Insomnia Market, By Therapy Type
 5.1 Introduction  
 5.2 Pharmacological Therapy 
  5.2.1 Over-the-Counter sleep aids
   5.2.1.1 Melatonin
   5.2.1.2 Antihistamines
   5.2.1.3 Valerian roots
   5.2.1.4 Other Herbal and dietary supplements
  5.2.2 Prescription sleep aids 
   5.2.2.1 Benzodiazepines
   5.2.2.2 Orexin Antagonists
   5.2.2.3 Melatonin Receptor Agonists
   5.2.2.4 Non-benzodiazepines
    5.2.2.4.1 Eszopiclone
    5.2.2.4.2 Zolpidem
    5.2.2.4.3 Zaleplon
   5.2.2.5 Other prescription sleep aids
    5.2.2.5.1 Tricyclic Antidepressants.
    5.2.2.5.2 Antipsychotics
    5.2.2.5.3 Chloral Derivatives
 5.3 Non-pharmacological Therapy 
  5.3.1 Medical Devices 
  5.3.2 Cognitive Behavioral Therapy
  5.3.3 Hypnotherapy 
  5.3.4 Paradoxical intention
  5.3.5 Sleep hygiene education
  5.3.6 Stimulus control 
  5.3.7 Other Alternative Therapies
   5.3.7.1 Acupuncture
   5.3.7.2 Bright light therapy
   5.3.7.3 Aroma therapy
   5.3.7.4 Music therapy
   5.3.7.5 Exercise/Yoga
   5.3.7.6 Biofeedback
     
6 Global Insomnia Market, By Disorder Duration
 6.1 Introduction  
 6.2 Chronic Insomnia  
 6.3 Transient Insomnia  
 6.4 Acute Insomnia  
     
7 Global Insomnia Market, By Disorder Condition
 7.1 Introduction  
 7.2 Sleep onset and/or Maintenance
 7.3 Poor Quality of Sleep 
 7.4 Other Disorder Condition 
     
8 Global Insomnia Market, By Formulation Type
 8.1 Introduction  
 8.2 Capsules   
 8.3 Tablets   
  8.3.1 Sublingual Tablets 
  8.3.2 Film-Coated Tablets 
 8.4 Oral mists   
     
9 Global Insomnia Market, By Geography 
 9.1 Introduction  
 9.2 North America  
  9.2.1 US  
  9.2.2 Canada  
  9.2.3 Mexico  
 9.3 Europe   
  9.3.1 Germany  
  9.3.2 U.K  
  9.3.3 France  
  9.3.4 Italy  
  9.3.5 Spain  
  9.3.6 Rest of Europe 
 9.4 Asia Pacific  
  9.4.1 Japan  
  9.4.2 China  
  9.4.3 India  
  9.4.4 Australia  
  9.4.5 New Zealand 
  9.4.6 South Korea 
  9.4.7 Rest of Asia Pacific 
 9.5 South America  
  9.5.1 Argentina  
  9.5.2 Brazil  
  9.5.3 Chile  
  9.5.4 Rest of South America
 9.6 Middle East & Africa  
  9.6.1 Saudi Arabia 
  9.6.2 UAE  
  9.6.3 Qatar  
  9.6.4 South Africa 
  9.6.5 Rest of Middle East & Africa
     
10 Key Developments   
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers 
 10.3 New Product Launch  
 10.4 Expansions  
 10.5 Other Key Strategies  
     
11 Company Profiling   
 11.1 Astellas   
 11.2 Biocodex S A  
 11.3 Consumer Healthcare Inc. 
 11.4 Dainippon Sumitomo  
 11.5 ECR Pharmaceuticals  
 11.6 Eisai Co.   
 11.7 Flynn Pharma  
 11.8 Johnson & Johnson  
 11.9 Meda Consumer Healthcare Inc.
 11.10 Merck & Co. Inc.  
 11.11 Neurim   
 11.12 Pernix Therapeutics  
 11.13 Pfizer Inc   
 11.14 Purdue Pharma L.P.  
 11.15 Sanofi Pasteur  
 11.16 SkyePharma  
 11.17 Takeda Pharmaceutical Company


List of Tables    
1 Global Insomnia Market Outlook, By Region (2014-2023) ($MN)
2 Global Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
3 Global Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
4 Global Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
5 Global Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
6 Global Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
7 Global Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
8 Global Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
9 Global Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
10 Global Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
11 Global Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
12 Global Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
13 Global Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
14 Global Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
15 Global Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
16 Global Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
17 Global Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
18 Global Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
19 Global Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
20 Global Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
21 Global Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
22 Global Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
23 Global Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
24 Global Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
25 Global Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
26 Global Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
27 Global Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
28 North America Insomnia Market Outlook, By Country (2014-2023) ($MN)
29 North America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
30 North America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
31 North America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
32 North America Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
33 North America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
34 North America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
35 North America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
36 North America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
37 North America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
38 North America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
39 North America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
40 North America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
41 North America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
42 North America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
43 North America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
44 North America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
45 North America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
46 North America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
47 North America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
48 North America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
49 North America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
50 North America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
51 North America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
52 North America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
53 North America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
54 North America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
55 Europe Insomnia Market Outlook, By Country (2014-2023) ($MN)
56 Europe Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
57 Europe Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
58 Europe Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
59 Europe Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
60 Europe Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
61 Europe Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
62 Europe Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
63 Europe Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
64 Europe Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
65 Europe Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
66 Europe Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
67 Europe Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
68 Europe Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
69 Europe Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
70 Europe Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
71 Europe Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
72 Europe Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
73 Europe Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
74 Europe Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
75 Europe Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
76 Europe Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
77 Europe Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
78 Europe Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
79 Europe Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
80 Europe Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
81 Europe Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
82 Asia pacific Insomnia Market Outlook, By Country (2014-2023) ($MN)
83 Asia pacific Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
84 Asia pacific Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
85 Asia pacific Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
86 Asia pacific Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
87 Asia pacific Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
88 Asia pacific Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
89 Asia pacific Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
90 Asia pacific Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
91 Asia pacific Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
92 Asia pacific Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
93 Asia pacific Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
94 Asia pacific Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
95 Asia pacific Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
96 Asia pacific Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
97 Asia pacific Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
98 Asia pacific Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
99 Asia pacific Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
100 Asia pacific Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
101 Asia pacific Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
102 Asia pacific Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
103 Asia pacific Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
104 Asia pacific Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
105 Asia pacific Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
106 Asia pacific Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
107 Asia pacific Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
108 Asia pacific Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
109 South America Insomnia Market Outlook, By Country (2014-2023) ($MN)
110 South America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
111 South America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
112 South America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
113 South America Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
114 South America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
115 South America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
116 South America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
117 South America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
118 South America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
119 South America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
120 South America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
121 South America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
122 South America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
123 South America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
124 South America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
125 South America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
126 South America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
127 South America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
128 South America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
129 South America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
130 South America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
131 South America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
132 South America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
133 South America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
134 South America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
135 South America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
136 Middle East & Africa Insomnia Market Outlook, By Country (2014-2023) ($MN)
137 Middle East & Africa Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
138 Middle East & Africa Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
139 Middle East & Africa Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
140 Middle East & Africa Insomnia Market Outlook, By Prescription sleep aids  (2014-2023) ($MN)
141 Middle East & Africa Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
142 Middle East & Africa Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
143 Middle East & Africa Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
144 Middle East & Africa Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
145 Middle East & Africa Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
146 Middle East & Africa Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
147 Middle East & Africa Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
148 Middle East & Africa Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
149 Middle East & Africa Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
150 Middle East & Africa Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
151 Middle East & Africa Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
152 Middle East & Africa Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
153 Middle East & Africa Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
154 Middle East & Africa Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
155 Middle East & Africa Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
156 Middle East & Africa Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
157 Middle East & Africa Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
158 Middle East & Africa Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
159 Middle East & Africa Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
160 Middle East & Africa Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
161 Middle East & Africa Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
162 Middle East & Africa Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials